Editas Medicine, Inc.
EDIT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $105 | $770 | $609 | $1,795 |
| - Cash | $132 | $124 | $142 | $204 |
| + Debt | $35 | $37 | $44 | $26 |
| Enterprise Value | $8 | $682 | $511 | $1,618 |
| Revenue | $32 | $78 | $20 | $26 |
| % Growth | -58.6% | 296.3% | -22.8% | – |
| Gross Profit | $32 | $72 | $13 | $20 |
| % Margin | 100% | 92.2% | 67.9% | 80.2% |
| EBITDA | -$233 | -$163 | -$220 | -$188 |
| % Margin | -721.4% | -208.8% | -1,114.1% | -736.3% |
| Net Income | -$237 | -$153 | -$220 | -$193 |
| % Margin | -733.7% | -196.1% | -1,118.3% | -753.6% |
| EPS Diluted | -2.88 | -2.02 | -3.21 | -2.85 |
| % Growth | -42.6% | 37.1% | -12.6% | – |
| Operating Cash Flow | -$210 | -$132 | -$177 | -$164 |
| Capital Expenditures | -$9 | -$5 | -$4 | -$8 |
| Free Cash Flow | -$219 | -$137 | -$181 | -$172 |